Heparid Syrup, containing the active ingredient Silymarin (NA), is a hepatoprotective agent widely used in the management of liver disorders. Silymarin, a flavonoid complex extracted from the seeds of Silybum marianum (milk thistle), exhibits potent antioxidant, anti-inflammatory, and antifibrotic properties, which contribute to its therapeutic efficacy in liver diseases. Heparid Syrup is indicated for the treatment of acute and chronic hepatitis, cirrhosis, and other conditions associated with hepatic dysfunction, including toxin-induced liver damage and fatty liver disease. The formulation aids in stabilizing hepatocyte membranes, promoting liver cell regeneration, and inhibiting the penetration of hepatotoxins. Additionally, Silymarin enhances glutathione levels, thereby improving the liver’s detoxification capacity. Heparid Syrup is generally well-tolerated, with a favorable safety profile and minimal adverse effects. It is administered orally, with dosage tailored according to the severity of liver impairment and patient response. The syrup form ensures ease of administration, particularly in pediatric and geriatric populations. Heparid Syrup should be used under medical supervision, especially in patients with severe hepatic or renal impairment. Concomitant use with other hepatotoxic drugs requires caution. Regular monitoring of liver function tests is recommended to assess therapeutic outcomes.